Document is current
Any future updates will be listed below
-
Authors
Mannino, David https://orcid.org/0000-0003-3646-7828
Weng, Stephen https://orcid.org/0000-0002-5281-9590
Germain, Guillaume https://orcid.org/0000-0002-4525-7673
Boudreau, Julien https://orcid.org/0009-0008-1316-9645
Tardif-Samson, Anabelle https://orcid.org/0009-0009-5118-1909
Forero-Schwanhaeuser, Sergio
Laliberté, François https://orcid.org/0000-0003-2601-6214
Gravelle, Patrick https://orcid.org/0000-0001-6296-8795
Compton, Chris H. https://orcid.org/0000-0002-7564-5343
Noorduyn, Stephen G. https://orcid.org/0000-0002-5936-5579
Paczkowski, Rosirene https://orcid.org/0009-0001-7151-4311
-
Funding
Funding for this research was provided by:
GSK
- License Information
-
More Information
Article History
Received: 18 November 2024
Accepted: 9 December 2024
First Online: 28 December 2024
Declarations
:
: David Mannino is a consultant for AstraZeneca, the COPD Foundation, Genentech, GSK, Regeneron, and Up-to-Date. David Mannino is also an expert witness on behalf of people suing the tobacco and vaping industries. Stephen Weng, Sergio Forero-Schwanhaeuser, Chris H Compton, Stephen G Noorduyn, and Rosirene Paczkowski are employees of GSK and/or hold financial equities in GSK. Stephen G Noorduyn is also a PhD candidate at McMaster University. Guillaume Germain, Julien Boudreau, Anabelle Tardif-Samson, François Laliberté, and Patrick Gravelle are employees of Groupe d’analyse, which received funding from GSK to conduct this study.
: This study complied with all applicable laws regarding patient privacy, as described in the Declaration of Helsinki. No direct patient contact or primary collection of individual human patient data has occurred in this study. This study used existing, fully de-identified data that complied with the requirements of the Health Insurance Portability and Accountability Act and the patient(s) cannot be identified, directly or through identifiers. Study results were in tabular form and aggregate analyses that omit patient identification; therefore, informed consent, ethics committee or Institutional Review Board approval were not required.
